PAH clinical trials at UCSD
1 in progress, 0 open to new patients
Sorry, not currently recruiting here
This is a multicenter double-blind, placebo-controlled study to evaluate the safety, efficacy and pharmacokinetics of 2 doses of CXA-10 on stable background therapy in 96 subjects 18 to 80 years of age with PAH.
La Jolla, California and other locations
Last updated: October 2, 2018